{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-data-sharing-transparency-in-public-health-emergencies”
},
“headline”: “SOP for Data Sharing/Transparency in Public Health Emergencies”,
“description”: “This SOP establishes procedures for data sharing and transparency in clinical trials conducted during public health emergencies. It ensures compliance with WHO expectations, ethical imperatives, and rapid dissemination of data for global health protection.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Data Sharing/Transparency in Public Health Emergencies

Purpose

The purpose of this SOP is to establish structured procedures for timely data sharing and transparency in clinical trials conducted during public health emergencies (e.g., pandemics, epidemics). It aligns with WHO guidance to ensure that trial results contribute rapidly to public health decision-making, while maintaining ethical and regulatory compliance.

Scope

This SOP applies to sponsors, CROs, investigators, regulatory affairs teams, and data managers involved in trials conducted during emergencies. It covers trial registration, expedited data sharing, publication requirements, and communication with regulators, WHO, and the public.

Responsibilities

• Sponsor: Ensures timely data release to WHO and national authorities.
• CRO: Facilitates operational aspects of emergency data sharing.
• Investigator: Ensures accurate and real-time reporting of trial data.
• Regulatory Affairs: Coordinates communication with health authorities and WHO.
• QA: Audits emergency data sharing records for compliance.

Accountability

The Sponsor’s Regulatory and Clinical Heads are accountable for ensuring that trial data are rapidly and transparently shared with global health authorities during emergencies.

Procedure

1. Trial Registration
1.1 Register trial in WHO ICTRP-recognized registry prior to enrollment.
1.2 Ensure registry updates every 30 days.
1.3 Document in Trial Registration Log (Annexure-1).

2. Interim Data Sharing
2.1 Submit interim safety and efficacy results to WHO and regulators within agreed timelines.
2.2 Share aggregated anonymized data with public health stakeholders.
2.3 Record in Interim Data Sharing Log (Annexure-2).

3. Final Results Disclosure
3.1 Publish trial results within 6 months of study completion in open-access platforms.
3.2 Notify WHO and regulators of data availability.
3.3 Document in Final Results Disclosure Log (Annexure-3).

4. Communication
4.1 Provide regular updates to trial participants and affected communities.
4.2 Maintain transparency through press releases, websites, or public dashboards.
4.3 Document in Communication Log (Annexure-4).

5. Archiving
5.1 Archive shared data, communications, and reports in TMF and ISF.
5.2 Record details in Data Archiving Log (Annexure-5).

Abbreviations

• SOP: Standard Operating Procedure
• WHO: World Health Organization
• ICTRP: International Clinical Trials Registry Platform
• CRO: Contract Research Organization
• QA: Quality Assurance
• TMF: Trial Master File
• ISF: Investigator Site File

Documents

1. Trial Registration Log (Annexure-1)
2. Interim Data Sharing Log (Annexure-2)
3. Final Results Disclosure Log (Annexure-3)
4. Communication Log (Annexure-4)
5. Data Archiving Log (Annexure-5)

References

• WHO – Data Sharing in Public Health Emergencies
• WHO ICTRP
• ICH GCP Guidelines

Version: 1.0

Approval Section

Annexures

Annexure-1: Trial Registration Log

Annexure-2: Interim Data Sharing Log

Annexure-3: Final Results Disclosure Log

Annexure-4: Communication Log

Annexure-5: Data Archiving Log

Revision History

For more SOPs visit: Pharma SOP

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-data-sharing-with-regulators-and-repositories”
},
“headline”: “SOP for Data Sharing with Regulators and Repositories”,
“description”: “This SOP defines procedures for sharing clinical trial data with regulators and repositories, ensuring compliance with FDA, EMA, WHO, CDSCO, and ICH GCP guidelines. It includes data anonymization, formatting, submission portals, timelines, and retention requirements.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Data Sharing with Regulators and Repositories

Purpose

The purpose of this SOP is to define procedures for the secure and compliant sharing of clinical trial data with regulators and public repositories. Data sharing enhances transparency, facilitates regulatory review, and supports global scientific collaboration while protecting subject confidentiality.

Scope

This SOP applies to sponsors, CROs, regulatory affairs, data management, statisticians, and QA staff responsible for preparing and submitting trial data. It covers sharing of clinical study reports (CSRs), patient-level data, anonymized datasets, safety data, and genomic or specialty datasets with regulatory authorities and repositories.

Responsibilities

• Sponsor: Ensures data sharing obligations are met in line with regulatory requirements.
• Regulatory Affairs: Manages submissions through portals such as FDA CDER NextGen, EMA Data Sharing, and WHO ICTRP repositories.
• Data Management: Prepares anonymized datasets and metadata for submission.
• Statisticians: Generate analysis outputs and ensure integrity of statistical datasets.
• QA: Conducts QC checks on data packages prior to submission.

Accountability

The Sponsor’s Regulatory Head is accountable for ensuring accurate and timely data sharing with regulators and repositories. QA is accountable for verifying data integrity and compliance with GCP and privacy regulations.

Procedure

1. Planning
1.1 Develop Data Sharing Plan outlining obligations, datasets, repositories, and timelines.
1.2 Maintain Data Sharing Plan Log (Annexure-1).

2. Data Preparation
2.1 Extract data post-database lock.
2.2 Anonymize patient-level data in compliance with GDPR and HIPAA.
2.3 Prepare standardized datasets (e.g., CDISC SDTM, ADaM).
2.4 Maintain Data Preparation Log (Annexure-2).

3. Regulatory Submissions
3.1 Submit datasets through regulatory portals (FDA, EMA, CDSCO).
3.2 Upload supporting documents such as CSR, protocols, and SAP.
3.3 Maintain Regulatory Submission Log (Annexure-3).

4. Repository Sharing
4.1 Share trial data with WHO ICTRP and approved repositories where applicable.
4.2 Document repository submissions in Repository Sharing Log (Annexure-4).

5. Quality Control
5.1 QA verifies completeness, accuracy, and anonymization adequacy of data packages.
5.2 Document QC in Data Sharing QC Log (Annexure-5).

6. Archiving
6.1 Archive submitted datasets, logs, and confirmation receipts in TMF.
6.2 Retain in compliance with global archiving standards.

Abbreviations

• SOP: Standard Operating Procedure
• CSR: Clinical Study Report
• QA: Quality Assurance
• CRO: Contract Research Organization
• TMF: Trial Master File
• CDISC: Clinical Data Interchange Standards Consortium
• SDTM: Study Data Tabulation Model
• ADaM: Analysis Data Model
• EMA: European Medicines Agency
• FDA: Food and Drug Administration
• WHO: World Health Organization
• CDSCO: Central Drugs Standard Control Organization
• HIPAA: Health Insurance Portability and Accountability Act
• GDPR: General Data Protection Regulation

Documents

1. Data Sharing Plan Log (Annexure-1)
2. Data Preparation Log (Annexure-2)
3. Regulatory Submission Log (Annexure-3)
4. Repository Sharing Log (Annexure-4)
5. Data Sharing QC Log (Annexure-5)

References

• ICH E6(R2/R3) – Data Sharing Requirements
• FDA – Study Data Standards and Submissions
• EMA – Policy on Clinical Data Publication
• CDSCO – Clinical Data Sharing Regulations
• WHO – Data Sharing Standards

Version: 1.0

Approval Section

Annexures

Annexure-1: Data Sharing Plan Log

Annexure-2: Data Preparation Log

Annexure-3: Regulatory Submission Log

Annexure-4: Repository Sharing Log

Annexure-5: Data Sharing QC Log

Revision History

For more SOPs visit: Pharma SOP